Diabetes decisions — 2019

The Board denied service connection for gastrointestinal disorder, including GERD and irritable bowel syndrome, prostate cancer, skin condition (keratosis), and diabetes mellitus due to a lack of evidence linking these conditions to the Veteran's military service. The Board found that there was no exposure to herbicides during service.,Service connection is not granted as the preponderance of the evidence does not support a finding that any of the claimed conditions are related to active duty.

The Board has remanded the claims for diabetes mellitus and bilateral neuropathy of lower extremities secondary to herbicide exposure due to new evidence received since the last decision.

The Veteran's diabetes mellitus, type II is presumed to be due to herbicide agent exposure during service. The claim for an initial compensable rating for bilateral hearing loss is remanded.

The Veteran's diabetes mellitus, Type II is granted as service connected due to exposure to herbicides during his military service in the Korean DMZ.

The Veteran's claims for service connection are remanded due to the need for additional evidence and examinations, including Gulf War illness evaluations.

The Board has granted service connection for diabetes mellitus type II and sleep apnea, finding that the conditions are related to exposure to herbicides while in active service.

The Board has granted the Veteran's claim for service connection for hypertension as secondary to his service-connected diabetes mellitus.

The Board has remanded the case due to insufficient medical opinions regarding whether the Veteran's service-connected conditions caused or contributed to his death. The VA must provide addendum opinions addressing these issues.

The Veteran's claim for tinnitus has been granted. The initial rating for major depressive disorder remains denied. The effective date for service connection of major depressive disorder is not earlier than April 15, 2016.,Remaining claims for service connection are pending and need further development.

The Board has remanded the Veteran's claims for diabetes mellitus type II and foot neuropathy due to insufficient medical opinions regarding service connection.

The Veteran's PTSD is currently rated at 70 percent, but the evidence does not support a higher rating.,The Veteran's diabetes mellitus is currently rated at 20 percent and there is no evidence of more than one daily injection of insulin or restricted diet and regulation of activities.

The Veteran's claim for service connection for diabetes mellitus was denied, and since the Veteran died during the appeal process, his claim is dismissed.

The Board has remanded the Veteran's claims for service connection due to incomplete development and the need for additional medical examination.

The Board has remanded the cases of hypertension and diabetes mellitus, type II for further development due to scheduling issues.

The Board has remanded the case due to insufficient evidence regarding the Veteran's exposure to herbicide agents during service, and a VA examination is needed to determine if diabetes mellitus is related to his military service.

The Board has determined that additional development is necessary to determine the nature and etiology of the Veteran's glaucoma, including whether it was caused or aggravated by his service-connected diabetes mellitus, type II, and/or diabetic retinopathy.

The Veteran's service-connected disabilities do not prevent him from obtaining and maintaining a substantially gainful occupation during the period of November 15, 2018 to April 9, 2019.

The Veteran's claim for an increased rating of diabetic retinopathy is remanded due to a duty to assist error.

The Veteran's claims for service connection for diabetes mellitus type II, bilateral hearing loss, and tinnitus were denied as there was no credible evidence of herbicide exposure or acoustic trauma during service. The Board found that the current conditions are not related to service.

The Veteran's claims for service connection for diabetes mellitus, prostate cancer, and skin cancer were denied. The Veteran's claim for a compensable rating for bilateral hearing loss from September 10, 2012 to February 19, 2019 was denied, while his claim for an evaluation in excess of 20 percent for bilateral hearing loss since February 20, 2019 was also denied.